China warns that eventually the whole world will pay the price for Trump's hardline stance.

The U.S. Treasury proposes including the biotechnology sector in investment restrictions towards China, alongside supercomputing and hypersonic technologies. China's state media argues that these measures contradict previous agreements between the two nations and continue Washington's efforts to hinder China's technological advancement. Biotechnology is seen as a field for mutually beneficial cooperation, with significant international licensing agreements projected by 2025. The sector is crucial for global health, and restrictions could impede scientific collaboration and innovation. American pharmaceutical companies have previously protested against strict investment limits, emphasizing the importance of China's role in global competitiveness. China's foreign investment remains strong, with a notable increase in high-tech sector investments this year. The commentary suggests that the U.S. should consider the views of its business community to facilitate cooperation with Chinese…